CHU Marseille — Marseille, France

Public research footprint of CHU Marseille, compiled from the ClinicalTrials.gov public registry.

102

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Familial Primary Pulmonary Hypertension · NSCLC (Advanced Non-small Cell Lung Cancer) · Ulcerative Colitis · Myotonic Dystrophy Type 1 (DM1)

Recently updated registry entries

NCT07486934 — Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants… (Recruiting)
NCT05299294 — Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old (Active Not Recruiting)
NCT06881784 — Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Marseille?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.